Principia Biopharma (PRNB) Cut to Sell at Zacks Investment Research

Retrieved on: 2019-01-12 00:18:44

Tags for this article:

Click the tags to see associated articles and topics

Principia Biopharma (PRNB) Cut to Sell at Zacks Investment Research. View article details on HISWAI:

Excerpt

<div><b>Sofinnova Ventures</b> Inc purchased a new stake in shares of Principia Biopharma in the third quarter valued at approximately $59,556,000. Laurion ...</div>

Article found on:

View Original Article